| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 7 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1682 | $1298 | ||
| Short term investments | $491 | $409 | ||
| Net receivables | $1011 | $1093 | $1194 | $1122 |
| Inventory | $20 | |||
| Total current assets | $3358 | $3266 | $2921 | $2921 |
| Long term investments | $15112 | $15763 | ||
| Property, plant & equipment | $430 | $436 | $447 | $447 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $18431 | $18378 | $18684 | $18684 |
| Current liabilities | ||||
| Accounts payable | $196 | $222 | $181 | $1295 |
| Deferred revenue | ||||
| Short long term debt | $1264 | $372 | ||
| Total current liabilities | $3561 | $3728 | $3233 | $3233 |
| Long term debt | $2057 | $1846 | $2905 | $3114 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $6558 | $6762 | $7620 | $7620 |
| Shareholders' equity | ||||
| Retained earnings | $9370 | $9280 | $8680 | $8680 |
| Other shareholder equity | -$959 | -$1087 | -$1077 | -$1021 |
| Total shareholder equity | $11616 | $11064 | ||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 10 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $392 | $820 | $778 | $1787 |
| Short term investments | $409 | $576 | $522 | $612 |
| Net receivables | $1194 | $1069 | $1125 | $1216 |
| Inventory | $20 | $29 | $28 | $26 |
| Total current assets | $2921 | $2811 | $2453 | $3975 |
| Long term investments | $15763 | $18900 | $19696 | $1334 |
| Property, plant & equipment | $447 | $414 | $502 | $545 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $13906 | |||
| Total investments | ||||
| Total assets | $18684 | $21711 | $22149 | $17881 |
| Current liabilities | ||||
| Accounts payable | $181 | $1222 | $227 | $217 |
| Deferred revenue | $866 | |||
| Short long term debt | $372 | $1647 | ||
| Total current liabilities | $3233 | $4891 | $2581 | $2652 |
| Long term debt | $3114 | $3114 | $3786 | $3772 |
| Total noncurrent liabilities | $5249 | |||
| Total debt | ||||
| Total liabilities | $7620 | $9762 | $8315 | $7901 |
| Shareholders' equity | ||||
| Retained earnings | $8680 | $7706 | $9149 | $5211 |
| Other shareholder equity | -$1021 | -$1155 | -$811 | -$689 |
| Total shareholder equity | $11064 | $11885 | $13834 | $9870 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 7 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1724 | $1815 | ||
| Cost of revenue | ||||
| Gross Profit | $1642 | $1815 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1227 | $1127 | ||
| Operating income | $688 | |||
| Income from continuing operations | ||||
| EBIT | $818 | |||
| Income tax expense | $77 | $20 | ||
| Interest expense | -$41 | |||
| Net income | ||||
| Net income | $300 | $678 | ||
| Income (for common shares) | $678 | |||
| (in millions $) | 31 Jan 2024 | 8 Mar 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6794 | $6627 | $5984 | |
| Cost of revenue | $3944 | |||
| Gross Profit | $6490 | $6627 | $2040 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $76 | |||
| Total operating expenses | $4540 | $5023 | $4812 | |
| Operating income | $1604 | $1172 | ||
| Income from continuing operations | ||||
| EBIT | $1383 | $1172 | ||
| Income tax expense | $417 | $259 | $71 | |
| Interest expense | -$316 | -$82 | ||
| Net income | ||||
| Net income | $2690 | $1338 | $1122 | |
| Income (for common shares) | $1338 | $1120 | ||
| (in millions $) | 30 Oct 2024 | 1 Aug 2024 | 7 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $841 | $678 | ||
| Operating activities | ||||
| Depreciation | $206 | $189 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $705 | $705 | ||
| Investing activities | ||||
| Capital expenditures | -$152 | -$132 | ||
| Investments | ||||
| Total cash flows from investing | $749 | $324 | -$223 | $3513 |
| Financing activities | ||||
| Dividends paid | -$712 | -$892 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $937 | $1570 | ||
| Total cash flows from financing | -$2207 | -$1245 | -$1702 | -$5626 |
| Effect of exchange rate | -$2 | $1 | ||
| Change in cash and equivalents | $433 | $1682 | $1298 | $229 |
| (in millions $) | 31 Jan 2024 | 8 Mar 2023 | 10 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $1338 | $5687 | $1122 | |
| Operating activities | ||||
| Depreciation | $724 | $770 | $307 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1915 | $1773 | $1745 | |
| Investing activities | ||||
| Capital expenditures | -$595 | -$487 | -$504 | |
| Investments | $367 | |||
| Total cash flows from investing | $3513 | -$462 | -$504 | -$138 |
| Financing activities | ||||
| Dividends paid | -$892 | -$732 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $3116 | $2486 | $297 | |
| Total cash flows from financing | -$5626 | -$1156 | -$2273 | -$644 |
| Effect of exchange rate | $1 | -$1 | ||
| Change in cash and equivalents | $229 | $291 | -$1009 | $962 |
| Market cap | $73.16B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 449.92M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 4.68% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.69 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.94 |
| Quick ratio | N/A |